HCPCS 2008: New Modifier Makes MUEs More Palatable in 2008

Why This Topic Matters

The article helps readers track HCPCS changes that can affect claim submission, denial management, and reporting of injectable medications. It is useful for coders who need to understand which 2008 updates impact modifier use and drug code selection.

Article Sections

1. MUE-related modifier update

   Introduces a new HCPCS modifier effective in 2008 and places it in the context of medically unlikely edits and claim review.

2. Modifier deletions and code-category changes

   Summarizes changes to certain HCPCS modifiers and the movement of some temporary codes into a different HCPCS code section.

3. Immune globulin code updates

   Describes the replacement of earlier HCPCS reporting options for immune globulin injections with newer J codes.

4. Orthopedic injectable code updates

   Covers revised HCPCS reporting for sodium hyaluronate-related injectable products and the associated code updates for 2008.